Experts Matter. Find Yours.

Aston University researchers to explore using AI and fibre-optic networks to monitor natural hazards and infrastructures

Aston University is leading a new £5.5 million EU research project Will focus on converting fibre-optic cables into sensors to detect natural hazards Could identify earthquakes and tsunamis and assess civil infrastructure. Aston University is leading a new £5.5 million EU research project to explore converting existing telecommunication fibre-optic cables into sensors which can detect natural hazards, such as earthquakes and tsunamis, and assess the condition of civil infrastructure. The project is called ECSTATIC (Engineering Combined Sensing and Telecommunications Architectures for Tectonic and Infrastructure Characterisation) and is part of the Horizon Europe Research and Innovation Action (RIA), which aims to tackle global challenges and boost the continent’s industrial competitiveness. Converting telecom fibres into sensors requires new digital signal processing to overcome the limited data storage and processing capabilities of existing communication networks. To address this the project will use localised, high performance digital processing that will integrate artificial intelligence and machine learning. The researchers’ goal is to minimise algorithms’ complexity while providing extremely accurate real-time sensing of events and network condition. The new laser interrogation and signal processing technologies will be tested using existing fibre optic networks, including those underwater, in cities, and along railway infrastructure to assess their potential. Delivered by a consortium of 14 partners across seven countries, from academic and non-academic sectors, the research will start in February 2025 and will last three and a half years. The Europe-wide team will be led by Professor David Webb who is based in the Aston Institute of Photonic Technologies (AIPT). Professor Webb said: “There are more than five billion kilometres of installed data communications optical fibre cable, which provides an opportunity to create a globe-spanning network of fibre sensors, without laying any new fibres. “These traverse the seas and oceans - where conventional sensors are practically non-existent - and major infrastructures, offering the potential for smart structural health monitoring.” Professor Webb will be joined by fellow researchers Professor Sergei Turitsyn, Dr Haris Alexakis and Dr Pedro Freire. For media inquiries in relation to this release, contact Nicola Jones, Press and Communications Manager, on (+44) 7825 342091 or email: n.jones6@aston.ac.uk

Life and Legacy of Lily Ledbetter

The life and legacy of Lily Ledbetter stand as a powerful testament to the ongoing fight for workplace equality and women's rights. As the face behind the landmark Ledbetter v. Goodyear Tire & Rubber Co. case and the namesake of the Lily Ledbetter Fair Pay Act, her story continues to resonate in today's battles for gender pay equity. This topic is especially relevant now as conversations around economic justice, corporate responsibility, and legislative change gain momentum across the globe. Ledbetter's fight highlights the enduring struggle for fair compensation and workplace equity, which remains a vital issue for the public. Key story angles that may interest a broad audience include: The impact of the Lily Ledbetter Fair Pay Act: Exploring how this legislation has shaped workplace policies and its continuing relevance in today's legal landscape. Gender pay equity today: Analyzing the wage gap across industries and efforts to close the divide, with data on current disparities. The personal and professional costs of discrimination: Investigating how pay inequality affects families, career progression, and long-term financial security, especially for women of color. The broader fight for workplace rights: Examining the ripple effects of the Ledbetter case on other forms of discrimination, such as race, age, and disability. Economic justice as a human rights issue: Connecting Ledbetter’s legacy to current global movements pushing for equal pay, labor rights, and anti-discrimination reforms. Corporate responsibility and transparency: Assessing how companies are addressing pay equity through transparency measures, audits, and policy shifts. Connect with an expert about the Life and Legacy of Lily Ledbetter: To search our full list of experts visit www.expertfile.com

Pittsburgh’s AI-Powered Renaissance

Carnegie Mellon University’s artificial intelligence experts come from a wide range of backgrounds and perspectives, representing fields including computer science, sustainability, national security and entrepreneurship. Ahead of the AI Horizons Summit highlighting the city's commitment to responsible technology, CMU experts weighed in on why they see Pittsburgh as a hub for human-centered AI.

Expert Opinion - The Undisclosed Risks of Off-brand Ozempic and Other Weight Loss Products

The popularity -- and price -- of brand-name injectable drugs like Ozempic, Wegovy, Mounjaro, and Zepbound has skyrocketed. But the soaring demand for these drugs -- used for weight loss as well as to control blood sugar levels and reduce the risk of heart disease -- and the limited supply as well as lack of generic options has also led to a flood of non-brand alternatives in the market. In a recent article for The Conversation, UConn expert C. Michael White, Distinguished Professor of Pharmacy Practice, issued a warning to consumers about the potential undisclosed risks of these off-brand products: High demand is driving GLP-1 wannabes The dietary supplement market has sought to cash in on the GLP-1 demand with pills, teas, extracts and all manner of other products that claim to produce similar effects as the brand names at a much lower price. Products containing the herb berberine offer only a few pounds of weight loss, while many dietary supplement weight loss products contain stimulants such as sibutramine and laxatives such as phenolphthalein, which increase the risk of heart attacks, strokes and cancer. The role of compounding pharmacies Unlike the dietary supplements that are masquerading as GLP-1 weight loss products, compounding pharmacies can create custom versions of products that contain the same active ingredients as the real thing for patients who cannot use either brand or generic products for some reason. These pharmacies can also produce alternative versions of brand-name drugs when official drug shortages exist. Since the demand for GLP-1 medications has far outpaced the supply, compounding pharmacies are legally producing a variety of different semaglutide and tirzepatide products. These products may come in versions that differ from the brand-name companies, such as vials of powder that must be dissolved in liquid, or as tablets or nasal sprays. Just like the brand-name drugs, you must have a valid prescription to receive them. The prices range from $250-$400 a month – still a steep price for many consumers. Compounding pharmacies must adhere to the FDA’s sterility and quality production methods, but these rules are not as rigorous for compounding pharmacies as those for commercial manufacturers of generic drugs. In addition, the products compounding pharmacies create do not have to be tested in humans for safety or effectiveness like brand-name products do. Proper dosing can also be challenging with compounded forms of the drugs. Companies that work the system For people who cannot afford a compounding pharmacy product, or cannot get a valid prescription for semaglutide or tirzepatide, opportunistic companies are stepping in to fill the void. These include “peptide companies,” manufacturers that create non-FDA approved knockoff versions of the drugs. From November 2023 to March 2024, my team carried out a study to assess which of these peptide companies are selling semaglutide or tirzepatide products. We scoured the internet looking for these peptide companies and collected information about what they were selling and their sales practices. We found that peptide sellers use a loophole to sell these drugs. On their websites, the companies state that their drugs are for “research purposes only” or “not for human consumption,” but they do nothing to verify that the buyers are researchers or that the product is going to a research facility. By reading the comments sections of the company websites and the targeted ads on social media, it becomes clear that both buyers and sellers understand the charade. Unlike compounding pharmacies, these peptide sellers do not provide the supplies you need to dissolve and inject the drug, provide no instructions, and will usually not answer questions. Peptide sellers, since they allegedly are not selling to consumers, do not require a valid prescription and will sell consumers whatever quantity of drug they wish to purchase. Even if a person has an eating disorder such as anorexia nervosa, the companies will happily sell them a semaglutide or tirzepatide product without a prescription. The average prices of these peptide products range from $181-$203 per month. Skirting regulations Peptide sellers do not have to adhere to the rules or regulations that drug manufacturers or compounding pharmacies do. Many companies state that their products are 99% pure, but an independent investigation of three companies’ products from August 2023 to March 2024 found that the purity of the products were far less than promised. One product contained endotoxin – a toxic substance produced by bacteria – suggesting that it was contaminated with microbes. In addition, the products’ promised dosages were off by up 29% to 39%. Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure. In this study, some companies never even shipped the drug, telling the buyers they needed to pay an additional fee to have the product clear customs. If a consumer is harmed by a poor-quality product, it would be difficult to sue the seller, since the products specifically say they are “not for human consumption.” Ultimately, consumers are being led to spend money on products that may never arrive, could cause an infection, might not have the correct dose, and contain no instructions on how to safely use or store the product. Dr. C. Michael White is an expert in the areas of comparative effectiveness and preventing adverse events from drugs, devices, dietary supplements, and illicit substances. Dr. White is available to speak with media -- click on his icon now to arrange an interview today.

Surprising Jobs Report: What It Means for the U.S. Economy

In news that far surpassed expectations, the U.S. added 254,000 jobs in September. The unemployement rate is also heading in the right direction with a slight dip this past month, resulting in a rate of 4.1%. This update comes after an agressive rate cut by the Federal Reserve. Economic expert, Jared Pincin, has pointed out the motivation behind the rate cut and the possible outcomes. Here are some key points and connections to the September job report from an article he was recently featured in: The rate cut was a signal that the Federal Reserve is now prioritizing the job market rather than inflation and it could be a sign that the ecomony is slowing. However, after the latest job report that blew expectations out of the water, could the ecomony be headed in a better direction? After this job report that added almost double the jobs projected, will the Federal Reserve continue to focus on employment rather than inflation? The Federal Reserve will meet again in November to discuss rate cuts. Will this strong jobs report give them flexibility as they gather to make decisons right after the U.S. election? If you are covering the recent jobs report or the U.S. economy and need to know more, let us help with your questions and stories. Dr. Jared Pincin is an expert on this subject and is available to speak to media regarding the job market and what this means for families in the United States – simply click on his icon or email mweinstein@cedarville.edu to arrange an interview.

VP Debate Recap

Dr. Meena Bose, professor of political science, executive dean of the Public Policy and Public Service program, and director of the Kalikow Center for the Study of the American Presidency, was interviewed by WNYW Fox 5 to give a recap of the October 1 vice presidential debate between Tim Walz and J.D. Vance. Bose is a professor of political science, executive dean of the Public Policy and Public Service program, and executive director of the Kalikow Center for the Study of the American Presidency.

Ghoulish discovery: Exploring YouTube's role in the rise of belief in the paranormal

In recent years, YouTube has become an influential platform for various communities, notably for enthusiasts of the paranormal and ghosts. Paul Brewer, University of Delaware communication professor, set out to see how this happens and what we can learn from this in terms of how individuals perceive other messaging that may sit at the fringes of mainstream belief. During the 1990s, a big wave of research erupted on how media messages might influence people's belief in paranormal topics with popular television shows like “Alien Autopsy” and “Crossing Over with John Edwards.” A second wave of research occurred in the mid-2000s in response to cable television series such as “Ghost Hunters” and “Finding Big Foot.” Since then, the media landscape has evolved beyond traditional outlets like print, television and radio to include multimedia, such as YouTube, TikTok and other platforms. In his latest work, published in the journal Cyberpsychology, Behavior and Social Networking, Brewer looked beyond consuming paranormal television to include the use of social media, especially YouTube. “If you think about the paranormal, YouTube is a platform that seems like an especially plausible candidate to shape people's beliefs because seeing is believing—and it is a very visual storytelling medium,” said Brewer. "It’s not just a fun, kooky idea to study. About half the public believes in UFOs and almost half the public believes in ghosts and haunted houses, even though these phenomena aren't recognized by mainstream science." By way of example, Brewer pointed to a fictional documentary-style show that claimed the National Oceanic and Atmospheric Administration (NOAA) knew about mermaids and was hiding evidence for them, including real video footage. The show included disclaimers, but viewers ignored them, revealing an important detail about the power of belief. Brewer is available to speak more broadly on the topic and his findings. He can be contacted by emailing mediarelations@udel.edu.

Democrats Sue Georgia Election Board

James Sample, professor of Constitutional Law, appeared on Scripps News to discuss the lawsuit filed by the Democratic National Committee and Democratic Party of Georgia to block that state’s controversial ballot hand-count rule from going into effect in the upcoming presidential election. James is available to speak with media - simply click on his icon now to arrange an interview today.